Temozolomide Vs PCV With RT (CODEL)
Sources
registry, as of 2026-11-07
https://clinicaltrials.gov/api/v2/studies?query.cond=glioma&query.term=IDH
ClinicalTrials.gov API v2: IDH-mutant glioma interventional records plus 34 individual records, retrieved 11.07.2026 (registry fields as entered by sponsors)
Brief source I16
registry, as of 2026-11-07
https://clinicaltrials.gov/study/NCT00887146
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
ClinicalTrials.gov API v2 record, retrieved 2026-11-07